B85/100
Desk Score
Dispatch #4Partner
Eden
High-disclosure compounded program — the clearest verification signals on the board, at a premium price.
Visit Eden ↗Partner — we may earn a commission, at no cost to you. It never changes the Desk Score.
- Semaglutide
- $239/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
Desk Score breakdown
Each of the six scored dimensions. See the methodology.
Price transparency78/100
State access96/100
Molecule range88/100
Onboarding speed82/100
Support responsiveness90/100
Licensing & trust92/100
What the Desk likes
- Strongest verification confidence on the board
- All 50 states covered
- Both molecules available
Where points come off
- Premium pricing relative to peers
- Compounded only
The Desk's briefing — B
Best for: People who weight clinical transparency and oversight over finding the cheapest rate.
Pricing and verification reflect Eden's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Eden's site. Not medical advice; see our disclosure.